ALTERA Usb blasterPL-USB-BLASTER-RCNALTERA Usb blaster 下载电缆 主要特性:• 支持1.8伏,2.5伏, 3.3伏和5.0伏系统 • 支持SignalTap II 逻辑分析仪 • 支持EPCS串行配置器件的主动串行配置模式 • 支持和Nios II嵌入式处理器系列 的通讯和调试 详细特性介绍:
1.支持1.8V, 2.5V、3.3V 和5.0V 应用系统.2.支持SignalTap II 嵌入式逻辑分析仪功能.3.支持ALTERA 公司全系列器件 CPLD:MAX3000、MAX7000、MAX9000 和MAX II 等 FPGA:Stratix、Stratix II、Cyclone、Cyclone II、ACEX 1K、APEX 20K 和FLEX 10K等 主动串行配置器件:EPCS1、EPCS4、EPCS16等 增强配置器件:EPC1、EPC4 等。
目前已经测试过的芯片有 Cyclone-------EP1C3、EP1C6、EP1C12、EP1C20, Cyclone II----EP2C8、EP2C35,EP2C20,EP2C70 FLEX10K------EPF10K10、EPF0K30 ACEX1K-------EP1K30 MAX7000-----MAX7128SLC84、MAX7128AETC100 MAX3000-----MAX3128 EPCS----------EPCS1、EPCS4、EPCS16 EPC------------EPC1、EPC44.支持NIOS调试,支持NIOS下的FLASH烧写.
5.支持三种下载模式(AS、PS和JTAG) 测试上面的芯片时,采用了三种不同的编程模式 JTAG 下载模式 :Cyclone、Cyclone II、Stratix II、Flex10K、Acex1K、Max7000 和Max3000 测试时采用 主动串行(AS)模式:EPCS1 和EPCS4、EPCS16 被动串行(PS)模式:Stratix 和Stratix GX测试时采用6.速度快,性能稳定. 下载FPGA 配置程序是ByteblasterII 的6 倍。在一些速度要求高的应用场合下仍可使用SignalTap II 嵌入式逻辑分析仪进行实时分析。调试Nios II处理器时同样可以处理一些实时应用. 7.使用方便, 只有要USB 口的计算机都能使用USB-Blaster。不象ByteblasterII 那样要求计算机带有并口。 目前许多笔记本电脑,甚至台式机都不再配备并口,此时ByteblasterII 将无法使用
由于公司网店和实体店同时进行销售,终价格和库存数量请和销售人员落实后再购买,请广大买家谅解!其他购买问题们会耐心为您解答。
产品简介:
※ 12位DA精度※ 模拟量输出通道:4路※ 输出频率1MS/s※ DA缓存:每路256K字RAM※ DA量程:±10V,±5V
鸿研电子提供的产品如下:
电脑平台类:
工控机、嵌入式无风扇计算机、加固工控机、工业平板电脑、工业显示器、
一体机、工业服务器、HMI人机界面、触摸屏
采集与控制类:
可编程控制器(PLC、PAC)、变频器、多功能数据采集卡(DAQ) 、运动控制卡、数字量 IO 卡、远程 IO模块
工业通讯类:
工业以太网交换机、串口联网服务器、现在总线网关、工业多串口卡
接口转换器(RS232 转 RS422/485、光电转换、串口转光纤、USB 转串口、中继器、集线器、USB HUB)
工业无线产品(无线串口服务器、无线 AP、无线接入控制、IP网关、工业 GSM/GPRS 路由器)
软件类: Windows 正版系统、组态软件、可根据客户需求定制开发机器视觉,运动控制,采集等软件
合作品牌商:
台湾系:研华、摩莎、泓格、台达
大陆系:阿尔泰、宇泰
日美系:西门子、三菱、欧姆龙
产品详细说明 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
精密天平,精密电子天平:
赛多利斯型CP系列是的实验室专业天平。凭借独创、的设计理念、的造型和高超的机电技术,CP创造了实验室称量的新标准。0.001mg-34kg 的25种型号,为实验室称量工作提供了高质量的产品,具有的价格/性能比。 | ||
CP型号标准配置具有以下的特性: | ||
● 有背景光的液晶显示屏(CP2P、CP2P-F、CP225D型号没有背景光),字体高度:16.5mm 0.001g精密天平防风罩的侧面玻璃板可取出,上盖与防风罩的一边相连,可以翻启 ● 精度0.01mg/0.1mg的天平有全玻璃防风罩 ● 双向数据接口RS232 ● 内置全自动校准砝码(微量/准微量/分析天平) ● 只需按一个键,就可以使用外校砝码进行全自动校准和调整(所有精密天平) ● 天平下部吊钩称量(造型5是选件)● 超载保护 符合 ISO/GLP 的记录和打印功能(连接赛多利斯 YDP03-OCE 或 PC 机)● 应用程序:百分比称量,净重/总和配方计算,动态称量/动物称重,单位换算,计数 ● 适应外部环境的数字滤波器 水平支脚、水平仪、防盗环(8.2kg以下的天平) ● 左、右去皮键满足不同的使用习惯 ● 触感反馈式按键 ● 防静电涂层玻璃防风罩,能地屏蔽外界静电荷的干扰● 40M超高速微处理器MC1 | ||
|
|
选用用Microchip公司新一代CAN控制器,符合CAN Ver2.0B标准,总线通讯速率为1Mbit/s。CAN收发器采用Philips公司PCA82C250,并于CAN控制器之间采用6N137高速光藕。整板电路设计简洁,。与主机之间采用SPI高速通讯,已应用与多种工业控制产品。CAN接口:单通道CAN2.0B(可扩展到双通道)主机接口:SPI,通讯速率10Mbit/s功耗:<50mA供电:3.3V(控制器)/5V(收发器)
A-1421-2 | Amyloid β-Protein (1-40) (mouse, rat) | C190H291N51O57S | 4233.78 | 144409-98-3 | H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-3 | (Arg3)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) E3R | C195H300N56O56S | 4356.94 | H-Asp-Ala-Arg-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-4 | (Asn(4-aminobutyl)1·7·23,Gln(4-aminobutyl)3·11·22)-Amyloid β-Protein (1-40) (Asp(4-aminobutylamide)1·7·23,Glu(4-aminobutylamide)3·11·22)-Amyloid β-Protein (1-40) | C218H355N65O52S | 4750.69 | H-Asn(4-aminobutyl)-Ala-Gln(4-aminobutyl)-Phe-Arg-His-Asn(4-aminobutyl)-Ser-Gly-Tyr-Gln(4-aminobutyl)-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln(4-aminobutyl)-Asn(4-aminobutyl)-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-5 | Biotinyl-Amyloid β-Protein (1-40) | C204H309N55O60S2 | 4556.16 | 183906-14-1 | Biotinyl-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-6 | (7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40), DAC-Amyloid ß-Protein (1-40) | C208H308N54O61S | 4573.13 | (7-Diethylaminocoumarin-3-yl)carbonyl-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-7 | FITC-β-Ala-Amyloid β-Protein (1-40) | C218H311N55O64S2 | 4790.33 | FITC-β-Ala-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-8 | (Gln9)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) G9Q | C197H300N54O59S | 4400.94 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gln-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-9 | (Gln22)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Dutch Mutation, Amyloid β-Protein (1-40) E22Q | C194H296N54O57S | 4328.88 | 144410-00-4 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-10 | (Gly21)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Flemish Mutation, Amyloid β-Protein (1-40) A21G | C193H293N53O58S | 4315.84 | 154362-03-5 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Gly-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-11 | (Gly22)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Arctic Mutation, Amyloid β-Protein (1-40) E22G | C191H291N53O56S | 4257.80 | 175010-18-1 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-12 | (Lys22)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Italian Mutation, Amyloid β-Protein (1-40) E22K | C195H300N54O56S | 4328.92 | 302905-01-7 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Lys-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-13 | (Arg6)-Amyloid β-Protein (1-40), Amyloid β-Protein (1-40) English Mutation, Amyloid β-Protein (1-40) H6R | C194H300N54O58S | 4348.91 | H-Asp-Ala-Glu-Phe-Arg-Arg-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-14 | (Asn7)-Amyloid β-Protein (1-40), Amyloid β-Protein (1-40) Tottori Mutation, Amyloid β-Protein (1-40) D7N | C194H296N54O57S | 4328.88 | H-Asp-Ala-Glu-Phe-Arg-His-Asn-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-15 | (Asn23)-Amyloid β-Protein (1-40), Amyloid β-Protein (1-40) Iowa Mutation, Amyloid β-Protein (1-40) D23N, Abeta (1-40) D23N | C194H296N54O57S | 4328.88 | 374796-72-2 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asn-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-16 | (Cys0)-Amyloid β-Protein (1-40) | C197H300N54O59S2 | 4433.01 | 208266-35-7 | H-Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-17 | (Nle35)-Amyloid β-Protein (1-40) | C195H297N53O58 | 4311.83 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val-OH | |
A-1423 | Amyloid β-Protein (1-42) | C203H311N55O60S | 4514.10 | 107761-42-2 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1424 | Amyloid β-Protein (42-1) | C203H311N55O60S | 4514.10 | 317366-82-8 | H-Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-OH |
A-1423-2 | Amyloid β-Protein (1-42) (mouse, rat) | C199H307N53O59S | 4418.01 | 166090-74-0 | H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1423-3 | (Arg17)-Amyloid β-Protein (1-42) | C203H312N58O60S | 4557.13 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Arg-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-4 | (D-Asp1)-Amyloid β-Protein (1-42) | C203H311N55O60S | 4514.10 | H-D-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-5 | Biotinyl-Amyloid β-Protein (1-42) | C213H325N57O62S2 | 4740.40 | Biotinyl-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-6 | Cys-Gly-Lys-Arg-Amyloid β-Protein (1-42) (Cys668,Gly669,Arg671)-Amyloid β/A4 Protein Precursor770 (668-713), (Cys668,Gly669,Arg671)-APP770 (668-713) | C220H343N63O64S2 | 4958.66 | H-Cys-Gly-Lys-Arg-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-7 | ent-Amyloid β-Protein (1-42) | C203H311N55O60S | 4514.10 | 342896-25-7 | H-D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-D-Ile-D-Ala-OH |
A-1423-8 | FITC-β-Ala-Amyloid β-Protein (1-42) | C227H327N57O66S2 | 4974.57 | FITC-β-Ala-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-9 | (Glu20)-Amyloid β-Protein (1-42) Amyloid β-Protein (1-42) F20E | C199H309N55O62S | 4496.04 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Glu-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-10 | (Gly22)-Amyloid β-Protein (1-42) Amyloid β-Protein (1-42) Arctic Mutation, Amyloid β-Protein (1-42) E22G | C200H307N55O58S | 4442.04 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-11 | (Met(O)35)-Amyloid β-Protein (1-42) Amyloid β-Protein (1-42) sulfoxide | C203H311N55O61S | 4530.10 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met(O)-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-12 | (Met(O2)35)-Amyloid β-Protein (1-42), Amyloid β-Protein (1-42) sulfone | C203H311N55O62S | 4546.10 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met(O2)-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1425 | Amyloid β-Protein (1-43) | C207H318N56O62S | 4615.21 | 134500-80-4 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-OH |
A-1426 | (Pyr3)-Amyloid β-Protein (3-42) | C196H299N53O55S | 4309.92 | 183449-57-2 | Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1427 | Amyloid β-Protein (6-20) | C86H119N23O23 | 1843.03 | 183745-82-6 | H-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-OH |
A-1428 | Amyloid β-Protein (10-20) | C71H99N17O16 | 1446.67 | 152286-31-2 | H-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-OH |
A-1429 | Amyloid β-Protein (10-35) | C133H204N34O37S | 2903.36 | 237753-66-1 | H-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
A-1430 | (Pyr11)-Amyloid β-Protein (11-40) | C143H226N38O39S | 3133.67 | 192377-94-9 | Pyr-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1431 | Amyloid β-Protein (12-28) Alzheimer's Disease β-Protein (12-28) | C89H135N25O25 | 1955.20 | 107015-83-8 | H-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH |
A-1432 | Amyloid β-Protein (1-46) | C223H347N59O65S | 4926.63 | 285554-31-6 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val-OH |
A-1433 | Acetyl-Amyloid β-Protein (15-20) amide | C42H63N9O8 | 822.02 | 189064-06-0 | Ac-Gln-Lys-Leu-Val-Phe-Phe-NH2 |
A-1434 | (Lys15)-Amyloid β-Protein (15-21) | C44H69N9O8 | 852.09 | 190775-14-5 | H-Lys-Lys-Leu-Val-Phe-Phe-Ala-OH |
A-1435 | (Arg15,Asp16·25,Pro18·21·23,Val22,Ile24)-Amyloid β-Protein (15-25) | C64H94N14O16 | 1315.54 | 182912-63-6 | H-Arg-Asp-Leu-Pro-Phe-Phe-Pro-Val-Pro-Ile-Asp-OH |
A-1435-2 | Gly-Amyloid β-Protein (15-25)-Gly-ε-aminocaproyl(-Lys)6 H-Gly-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Gly-εAhx-Lys-Lys-Lys-Lys-Lys-Lys-OH | C105H178N28O26 | 2248.74 | 184951-46-0 | H-Gly-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Gly-ε-aminocaproyl-Lys-Lys-Lys-Lys-Lys-Lys-OH |
A-1436-2 | ent-[Amyloid β-Protein (20-16)]-β-Ala-D-Lys(ent-[Amyloid β-Protein (16-20)]) ent-[retro-Amyloid β-Protein (16-20)]-β-Ala-D-Lys(ent-[Amyloid β-Protein (16-20)]), (ffvlk)2(βA)k (tandem dimer) | C79H119N15O13 | 1486.91 | H-D-Phe-D-Phe-D-Val-D-Leu-D-Lys-β-Ala-D-Lys(D-Lys-D-Leu-D-Val-D-Phe-D-Phe-H)-OH | |
A-1436 | Amyloid β-Protein (16-20) | C35H52N6O6 | 652.84 | 153247-40-6 | H-Lys-Leu-Val-Phe-Phe-OH |
A-1437 | (Pro18,Asp21)-Amyloid β-Protein (17-21) | C33H43N5O8 | 637.73 | 182912-74-9 | H-Leu-Pro-Phe-Phe-Asp-OH |
A-1437-2 | Acetyl-(Pro18,Asp21)-Amyloid β-Protein (17-21) amide Ac-LPFFD-NH2 | C35H46N6O8 | 678.79 | 339990-02-2 | Ac-Leu-Pro-Phe-Phe-Asp-NH2 |
A-1437-3 | Amyloid β-Protein (20-29) | C43H66N12O17 | 1023.07 | 311818-43-6 | H-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-OH |
A-1438 | Amyloid β-Protein (22-35) | C59H102N16O21S | 1403.62 | 144189-71-9 | H-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
A-1439 | Amyloid β-Protein (25-35) | C45H81N13O14S | 1060.28 | 131602-53-4 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
A-1439-2 | (Met(O)35)-Amyloid β-Protein (25-35) | C45H81N13O15S | 1076.28 | 292147-12-7 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met(O)-OH |
A-1439-4 | (Nle35)-Amyloid β-Protein (25-35) | C46H83N13O14 | 1042.24 | 163265-32-5 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-OH |
A-1440 | Amyloid β-Protein (35-25) | C45H81N13O14S | 1060.28 | 147740-73-6 | H-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-OH |
A-1439-3 | Amyloid β-Protein (25-35) amide | C45H82N14O13S | 1059.30 | 147490-49-1 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 |
A-1441 | Amyloid β-Protein (29-40) | C49H88N12O13S | 1085.38 | 184865-04-1 | H-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1442 | Propionyl-Amyloid β-Protein (31-34) amide | C23H43N5O5 | 469.63 | 256419-86-0 | Propionyl-Ile-Ile-Gly-Leu-NH2 |
A-1443 | Amyloid β-Protein (31-35) | C25H47N5O6S | 545.74 | 149385-65-9 | H-Ile-Ile-Gly-Leu-Met-OH |
A-1445-2 | Cys-Gly-His-Gly-Asn-Lys-Ser-Amyloid β-Protein (33-40) | C58H99N19O18S2 | 1414.67 | H-Cys-Gly-His-Gly-Asn-Lys-Ser-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1445 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40) | C51H93N15O14S2 | 1204.52 | H-Cys-Gly-Lys-Lys-Gly-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1446 | Amyloid β-Protein (33-42) Amyloid β/A4 Protein Precursor770 (704-713), APP770 (704-713) | C41H74N10O11S | 915.17 | 178949-81-0 | H-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1447 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (35-40) | C43H79N13O12S2 | 1034.31 | H-Cys-Gly-Lys-Lys-Gly-Met-Val-Gly-Gly-Val-Val-OH | |
A-1444 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (36-42) | C47H86N14O13S | 1087.35 | H-Cys-Gly-Lys-Lys-Gly-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1448 | Non-Aβ Component of Alzheimer's Disease Amyloid NAC | C141H235N39O49 | 3260.65 | 154040-19-4 | H-Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val-OH |
A-1449 | Amyloid β-Protein (1-14) | C73H99N23O25 | 1698.73 | 186319-74-4 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-OH |
A-1450 | Amyloid ß-Protein (37-39) | C9H17N3O4 | 231.25 | 20274-89-9 | H-Gly-Gly-Val-OH |
A-1451 | (Leu16)-Amyloid β-Protein (16-19) | C26H42N4O5 | 490.64 | 24205-68-3 | H-Leu-Leu-Val-Phe-OH |
A-1452 | (Nle35)-Amyloid β-Protein (1-42) | C204H313N55O60 | 4496.06 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1453 | Methoxysuccinyl-Amyloid β-Protein (39-42)-p-nitroanilide | C30H46N6O9 | 634.73 | MeOSuc-Val-Val-Ile-Ala-pNA | |
A-1454 | Amyloid β-Protein (38-40) | C9H17N3O4 | 231.25 | 21835-35-8 | H-Val-Gly-Gly-OH |
A-1502 | Angiogenin (108-122) | C78H125N25O23 | 1781.01 | 112173-49-6 | H-Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-OH |
A-1503 | Angiogenin (108-123) | C83H132N26O24 | 1878.12 | 112173-48-5 | H-Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro-OH |
A-1601 | Angiotensin A Ala-Angiotensin III, (Ala1)-Angiotensin II | C49H71N13O10 | 1002.18 | 51833-76-2 | H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
A-1602 | Angiotensin I Ang I, Angiotensinogen (1-10) | C62H89N17O14 | 1296.50 | 484-42-4 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-2 | Acetyl-Angiotensin I | C64H91N17O15 | 1338.53 | 67509-13-1 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-3 | Biotinyl-Angiotensin I | C72H103N19O16S | 1522.79 | Biotinyl-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH | |
A-1602-4 | (Des-Asp1)-Angiotensin I | C58H84N16O11 | 1181.41 | 56317-01-2 | H-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-5 | (Val5,Asn9)-Angiotensin I Angiotensin I (bullfrog) | C59H86N16O15 | 1259.43 | H-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH | |
A-1603 | Angiotensin I (1-9) | C56H78N16O13 | 1183.34 | 34273-12-6 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-OH |
A-1604 | Angiotensin (1-12) (human) Angiotensinogen (1-12) (human), Proangiotensin-12 (human) | C73H109N19O16 | 1508.79 | 136865-09-3 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-OH |
A-1604-2 | Angiotensin (1-12) (mouse, rat) Angiotensinogen (1-12) (mouse, rat), Proangiotensin (1-12) (mouse, rat) | C77H109N19O17 | 1572.83 | 914910-73-9 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-OH |
上海仁彩自动化科技有限公司
联系人:徐生波(销售经理)
手 机:13817238655 15001934687
Q Q:2873364134
传 真:
地 址:上海市金山区枫泾镇新泾路59号电气数据 | |
单位长度阻尼量 | |
| 0.0025 dB/m |
| 0.0040 dB/m |
| 0.022 dB/m |
| 0.042 dB/m |
波阻 | |
| 150 Ω |
| 270 Ω |
| 185 Ω |
| 150 Ω |
相对对称公差 | |
| 10 % |
| 10 % |
| 10 % |
单位长度的回路电阻 / 最大值 | 110 Ω/km |
单位长度的屏蔽电阻 / 最大值 | 9.5 Ω/km |
每一长度的容量 / 在1 kHz时 | 28.5 pF/m |
工作电压 | |
| 100 V |
机械数据 | |
电线数量 | 2 |
屏蔽层规格 | 重叠的铝胶合箔,包裹镀锡铜线制成的屏蔽编织层 |
FastConnect | 是 |
外径 | |
| 0.65 mm |
| 2.55 mm |
| 5.4 mm |
| 8 mm |
外径的对称公差 / 电缆护套 | 0.4 mm |
材料 | |
| PE |
| PVC |
| PVC |
颜色 | |
| 红色 / 绿色 |
| 紫色 |
弯曲半径 | |
| 37.5 mm |
| 75 mm |
拉力负荷 / 最大值 | 100 N |
单位长度重量 | 80 kg/km |
许可的环境条件 | |
安装时 | |
| -40…+75 °C |
| -40…+75 °C |
| -40…+75 °C |
| -40…+75 °C |
| 20 Cel 时测量电气属性,根据 DIN 47250 第 4 部分或 DIN VDE 0472 进行检查 |
耐化学性 | |
| 耐抗力受条件影响 |
| 耐抗力受条件影响 |
放射折射性 / 抵抗 UV 射线 | 耐抗力 |
产品特点、功能、组件 / 概述 | |
产品特点/不含硅 | |
| 否 |
是 | |
标准、规范、许可 | |
UL/ETL 列表 / 300 V 评级中 | 是:c(UL)us, CMG / CL3 / Sun Res |
资格证明 | |
| 是 |
| 是 |
| 是 |
船级社 | |
| 否 |
| 否 |
| 否 |
| 否 |
| 否 |
否 | |
| 否 |
SIMATIC NET, PROFIBUS 快速标准电缆 GP, 2 芯, 屏蔽, 为快速安装而特殊设计,最大长度: 1000m, 最小订购数量: 20m, 按米销售
6XV1830-0EH10 西门子DP总线,PROFIBUS通讯电缆
概述
6XV1830-0EH10
SIMATIC NET, PROFIBUS 快速标准电缆 GP, 2 芯, 屏蔽, 为快速安装而特殊设计,最大长度: 1000m, 最小订购数量: 20m, 按米销售
Overview
■用于不同应用区域的不同类型(例如,地下电缆,拖曳电缆,危险区域(Zone 1 和 Zone 2)) ■双层屏蔽,抗干扰性能好 ■阻燃总线连接电缆(不含卤素)。 ■由于电缆上印有以米表示的长度标记,因此易于确定长度 ■UL 认证
PROFIBUS双芯屏蔽电缆商品信息
![]() | 6GK1905-0EA10 SIMATIC NET,PB FC M12 PLUG PRO M12 插头式连接器,带有坚固金属外壳和 FC 连接方法,带轴向电缆出口,和 ET200PRO 共用,插针连接器(B 编码),每包 5 件 | ||
![]() | 6GK1905-0EB10 SIMATIC NET,PB FC M12 PLUG PRO M12 插头式连接器,带有坚固金属外壳和 FC 连接方法,带轴向电缆出口,和 ET200PRO 共用,插针连接器(B 编码),每包 5 件 | ||
![]() | 6GK1905-6AA00 SIMATIC NET, PROFIBUS FastConnect 剥线工具, 用于 PROFIBUS FastConnect 总线电缆的快速剥线 | ||
![]() | 6GK1905-6AB00 SIMATIC NET, PROFIBUS FastConnect 刀片盒, 剥线工具备用刀片盒,共 5片 | ||
![]() | 6XV1830-0EH10 SIMATIC NET, PROFIBUS 快速标准电缆 GP, 2 芯, 屏蔽, 为快速安装而特殊设计,最大长度: 1000m, 最小订购数量: 20m, 按米销售 | ||
![]() | 6XV1830-0EN20 SIMATIC NET, PROFIBUS 标准总线电缆, 2 芯, 屏蔽, 为快速安装而特殊设计, 20 m | ||
![]() | 6XV1830-0EN50 SIMATIC NET, PROFIBUS 标准总线电缆, 2 芯, 屏蔽, 为快速安装而特殊设计, 50 m | ||
![]() | 6XV1830-0ET10 SIMATIC NET, PROFIBUS 标准总线电缆, 2 芯, 屏蔽, 为快速安装而特殊设计, 100m | ||
![]() | 6XV1830-0ET20 SIMATIC NET, PROFIBUS 标准总线电缆, 2 芯, 屏蔽, 为快速安装而特殊设计, 200 m | ||
![]() | 6XV1830-0ET50 SIMATIC NET, PROFIBUS 标准总线电缆, 2 芯, 屏蔽, 为快速安装而特殊设计, 500 m |
网卡及电缆 6es7 972-0cb20-0xa0 usb接口编程适配器(usb接口编程电缆) 6es7 972-0cb35-0xa0 ts适配器ii 用于调制解调器远程服务 6es7 972-0cc35-0xa0 ts适配器ii 用于isdn 远程服务 6gk1 561-1aa01 cp5611网卡(pci总线软卡,支持mpi,ppi,profibus-dp) 6gk1 551-2aa00 cp5512网卡(pcmcia总线软卡,支持mpi,ppi,profibus-dp,笔记6xv1 820-5bh50 光纤电缆 含bfoc (5米) 6xv1 820-5bt10 光纤电缆 含bfoc (100米) 6gk1 901-0da20-0aa0 bfoc接头(每包20只) 6es7 901-0bf00-0aa0 5米mpi电缆 6es7 901-1bf00-0xa0 rs232电缆 6es7 195-7hf80-0xa0 dp/pa耦合器有源总线单元 6gk1 905-0aa00 splitconnect分接头(10件) 6gk1 905-0ad00 splitconnect终端(ex)(5件) 6gk1 905-0ab10 splitconnect m12输出端(5件) 6gk1 905-0ac00 splitconnect 耦合器(10件)
Aquarius双光束紫外分光光度计
强大内部控制:Aquarius双光束紫外分光光度计计算系统含强大软件,操作迅速,容易使用。标准软件非
常,需要时可随时通过E-SEF扩充,装入额外的软件模块。 双光束光学系统:Aquarius双光束紫外
分光光度计是一种对称的双光束系统,测量十分,时间稳定性高。样品和基准光束具有同样的抽
样空间和设备,可满足广泛的实验要求,不只限于基准光束中的单样品池。食品专用分光光度计用于食品、饮料分析的DietQuest: Cecil仪器中有三种预先编程的DietQuest分光光度计,用于食品
、饮料分析。方法包括单、多波长测量和光谱扫描。水分析专用分光光度计用于水分析:AquaQuest 4000系列分光光度计是一种专门设计用来满足水分析分光光度计要求的仪器,有
可见光和紫外两种多功能性,AquaQuest 4000系列仪器具备所需要的灵活性和性能,它们可进行波长扫描
、样品池程序设计、分批取样、波长程序设计、时间线图表以及反应动力学。生物分析专用分光光度计 BioQuest: 设计小巧,1.8nm光学带宽,生物分析程序化,为一种功能强大的通用双光束扫描分光光度
计生物分光光度计:除生物分析和分子生物功能已预先程序化外,BioQuest和BioAquarius还具有紫外可
见分光光度计的一切正常功能,如扫描、时间线图表、吸光率、单波长测量浓度或可见度、样品池、波长
程序化、方法保存等。蛋白质分析核酸分析;浓度曲线符合的标准:反应动力学:小样品测量方法生成与
保存:数据流-数据到微机。药物溶解专用分光光度计该系统由几部分来构成:溶解测试机,溶解测试软件,相对应的分光光度计蠕动泵,以及相关选配件构成
FreeForm Plus触觉式设计软件
FreeForm Modeling Plus电脑雕刻笔触觉式设计软件是源自于1990年美国麻省理工学院(MIT)的研究项目,SensAble Technologies公司将3D Touch的技术应用到计算机内,为人类使用计算机起了重大的改变,具有3D力回馈系统(3D force-feedback systems)的FreeForm Modeling Plus触觉软件是世界上第一套能让设计师及雕刻家在电脑上利用触觉的方式就能完成3D模型的建构的系统。设计师可以随心所欲并且快速地创造出自己想要的复杂模型,就像雕刻黏土一样真实、生动,完全摆脱传统3D软件的束缚,将设计师的创意、灵感及想表达的意图完美地呈现出来,让产品设计有更大的突破。
Freeform Modeling Plus电脑雕刻笔完全摆脱了一般3D设计软件的限制,设计师不需要继续在复杂的电脑程序-数学方程式、鼠标与键盘指令、程序化的方法等阻碍下工作,系统提供了我们与真实世界互动的最基本方式——触觉,你可以通过触感,与您的模型进行直接和自然的互动。例如,一个像恐龙一样复杂的三维数字模型,设计师30分钟就可以解决问题,大大缩短了传统3D设计软件的制作周期,这样,您将拥有更多的时间和精力投身于真正的挑战,将您更多的创意转变为高品质的产品或工艺作品
同时,它也将实体功能带入了数字领域,这样一来,您就可以通过一个自然、类比的互动过程获得一个珍贵的数字化的三维模型。简单、直接的触觉互动;精确、细微的触觉控制,这一切都让你随心所欲的将你的设计理念和美感赋予您充满智慧和富有创意的精品之作,世界各地的设计家已渐渐开始发现FreeForm Modeling Plus系统在这些行业所能够带来的好处,从工业产品、玩具与游戏、礼品与鞋子,到消费电器、日用品,以及汽车内部设计,无不受用无穷,使设计过程变的十分方便。
FreeForm Modeling Plus电脑雕刻笔模型制作:
● 以灵活简便的功能取代令人头疼的复杂电脑程序。
● 开启计算机与设计师之间的设计理念的交流之门。
● 使用实体、类比介面来创建一个直观、可调度的数字模型。
● 允许设计师获得形态与功能的理想调和。
● 激励探索与反复思考创建难以数字化描述的理想作品。
|